EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Risk factors for disease generalization in acetylcholine receptor antibody-positive ocular myasthenia: a multicenter retrospective study

Lorenzo Verriello, Roberto Sartor, Fabrizio Bellizzi, Chiara Dalla Torre, Maria Elena Pessa, Marco Belluzzo, Alessio Bratina, Magda Quagliotto, Chiara Rosa Mancinelli, Michele Rana, Fulvio Pasquin, Martina Fabris und 5 weitere

Frontiers in Neurology · 25.05.2026 · 17

DOI: 10.3389/fneur.2026.1802425 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Neurology, online erschienen am 25.05.2026. Verfasst von Lorenzo Verriello und 16 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Unit, Department of Head-Neck and Neurosciences, Santa Maria della Misericordia University Hospital, Udine, Italy. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to identify factors associated with secondary generalization in patients with ocular-onset myasthenia gravis (OoMG) who were positive for anti–acetylcholine receptor (AChR) antibodies. Early identification of patients at higher risk of progression to generalized myasthenia gravis (gMG) is clinically relevant to optimize therapeutic strategies and improve long-term outcomes.

Methods

We conducted a multicenter retrospective cohort study including patients with anti-AChR–positive OoMG recruited from three Italian neurology centers. Demographic, clinical, electrophysiological, and serological data were collected. Univariable and multivariable Cox regression analyses were performed to identify factors associated with disease generalization.

Results

Among 85 patients, 40 (47.1%) developed gMG during follow-up. In univariable Cox regression, higher anti-AChR antibody titers (HR 3.37, 95% CI 1.53–7.43; p = 0.002) and abnormal repetitive nerve stimulation of facial muscles (HR 2.49, 95% CI 1.16–5.34; p = 0.020) were significantly associated with secondary generalization. However, no independent predictors were identified in multivariable analysis.

Conclusion

Higher anti-AChR antibody titers and abnormal facial repetitive nerve stimulation were associated with an increased risk of secondary generalization in seropositive OoMG. Although these factors did not independently predict generalization in multivariable analysis, their combined assessment may support early clinical risk stratification. Larger prospective studies are warranted to validate these findings and refine prognostic assessment.

Schlagwörter

Stichwörter der Autor:innen

anti-AChR antibodiesocular myasthenia gravispredictive factorsrepetitive nerve stimulationsecondary generalization

Autor:innen und Institutionen

  • Neurology Unit, Department of Head-Neck and Neurosciences, Santa Maria della Misericordia University Hospital, Udine, Italy.
  • Severe Acquired Brain Injury Unit, Department of Rehabilitation Medicine, Institute of Physical and Rehabilitation Medicine, University Hospital of Udine, Udine, Italy.
  • University of Udine, Udine, Italy.
  • Clinical Neurology Unit, Department of Head-Neck and Neurosciences, Santa Maria della Misericordia University Hospital, Udine, Italy.
  • Clinical Neurology Unit, Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.
  • Neurology Unit, Department of Medical, Gorizia-Monfalcone Hospital, Gorizia, Italy.

Zitieren

APA

Verriello, L., Sartor, R., Bellizzi, F., Dalla Torre, C., Pessa, M. E., Belluzzo, M., Bratina, A., Quagliotto, M., Mancinelli, C. R., Rana, M., Pasquin, F., Fabris, M., Pauletto, G., Isola, M., De Martino, M., Manganotti, P., & Valente, M. (2026). Risk factors for disease generalization in acetylcholine receptor antibody-positive ocular myasthenia: a multicenter retrospective study. Frontiers in Neurology, 17. https://doi.org/10.3389/fneur.2026.1802425

Vancouver

Verriello L, Sartor R, Bellizzi F, Dalla Torre C, Pessa ME, Belluzzo M, et al. Risk factors for disease generalization in acetylcholine receptor antibody-positive ocular myasthenia: a multicenter retrospective study. Frontiers in Neurology. 2026;17. doi:10.3389/fneur.2026.1802425

BibTeX
@article{Verriello2026,
  author = {Verriello, Lorenzo and Sartor, Roberto and Bellizzi, Fabrizio and Dalla Torre, Chiara and Pessa, Maria Elena and Belluzzo, Marco and Bratina, Alessio and Quagliotto, Magda and Mancinelli, Chiara Rosa and Rana, Michele and Pasquin, Fulvio and Fabris, Martina and Pauletto, Giada and Isola, Miriam and De Martino, Maria and Manganotti, Paolo and Valente, Mariarosaria},
  title = {Risk factors for disease generalization in acetylcholine receptor antibody-positive ocular myasthenia: a multicenter retrospective study},
  journal = {Frontiers in Neurology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fneur.2026.1802425}
}
Kostenlos starten →